Statistics
Publications
9
Citations
316
H-Index
9
Active since
2019
Affiliations
Dan E. Lind is an author at University of Gothenburg specializing in molecular oncology, oncology, and oncogenic signaling pathways.
Publications per year
2019–2024
9
9
ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation
Marcus Borenäs, Ganesh Umapathy, Wei‐Yun Lai et al. · The EMBO Journal · 2021 · 64 citations · Full text
Medicine, Oncology, Pharmacology +17
ATR inhibition enables complete tumour regression in ALK-driven NB mouse models
Joanna Szydzik, Dan E. Lind, Badrul Arefin et al. · Nature Communications · 2021 · 57 citations · Full text
Medicine, Cancer Biology, Oncology +17
Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells
Diana Cervantes-Madrid, Joanna Szydzik, Dan E. Lind et al. · Scientific Reports · 2019 · 28 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 9